3Furberg CD,Psaty BM,Manolio TA,et al.Prevalance of artiial fibrillation in elderly subjects[J].Am J Cardiol,1994,74(3):236-241.
4Stroke prevention in atrial fibrillation investigators.Adjusted-dose warfarin versus low-intensity,fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation:Stroke prevention in atrial fibrillation Ⅲ randomized clinic trial[J].Lancet,1996,348:633-638.
6Levine MN,Raskob G,Landefeld S,et al.He morrhagic complications of anticoagulant treatment[J].Chest,2001,119(1Suppl):108S-121S.
7LAUNBJERG J, EGEBLAD H, HEAF J, et al, Bleeding complications to oral anticoagulant thrapy: multivariate analysis of 1010 treatment years in 551 outpatients[J]. J Intern Med, 1991, 229:351.
8Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med, 1994; 154(13): 1449- 1457. Erratum in: Arch Intern Med, 1994; 154(19):2254
9Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation.Circulation, 1998;97(13): 1231 - 1233
10Albers GW, Amarenco P, Easton JD, et al.Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004; 126(3 Suppl) :483S- 512S. Review.
